Biosimilars and Biologics

Bioequivalence focuses on the equivalence of release of the active pharmaceutical ingredient from the pharmaceutical product and its subsequent absorption into the systemic circulation. This session has most extreme significance in setting to the way that lone an appropriately bioequivalent sedate competitor that adjusts the outcomes in all regards to the first authorized item can be called asBiosimilar tranquilize.

• Strategies for the Bioequivalence Assessment of Topical Dosage Forms
• Evaluation of Highly Variable Drugs and Drug Products
• Bioequivalence Approaches for Transdermal Dosage Forms
• Bioequivalence Assessment of Respiratory Dosage Form